6 unknown. 6 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Unknown 6 |
| Phase 2 | 4 | Unknown 4 |
Follow Child Development Disorders, Pervasive: new trials by email Literature Review of Child Development Disorders, Pervasive trials Research Report on Child Development Disorders, Pervasive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of MAD as add-on Therapy in Comparison With Standard of Care in Children With ASD Modified Atkin's Diet with standard of care, Standard of Care - Modified Atkins Diet, Autism Spectrum Disorder | Phase 2 / Phase 3 | Unknown | All India Institute of Medical Sciences | 80 | 2024-03-20 | 2024-03-18 |
| Telehealth-Enabled Versus In-Person Parent-Mediated Behavioral Treatment for Challenging Behaviors in Children With ASD Behavior therapy, Psychoeducation - Autism Spectrum Disorder | Phase 2 / Phase 3 | Unknown | Stanford University | 90 | 2024-01-05 | 2024-08-27 |
| Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances Tasimelteon Oral Capsule, Tasimelteon Liquid Suspension - Autism Spectrum Disorder, Sleep Disorder | Phase 3 | Unknown | Vanda Pharmaceuticals | 100 | 2021-07-28 | 2024-03-21 |
| Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex Everolimus, Placebo - Tuberous Sclerosis Complex, TSC Related Cognitive Disability | Phase 2 / Phase 3 | Unknown | Erasmus Medical Center | 60 | 2012-11-01 | 2015-05-05 |
| Group Psychoeducational Program for Mothers of Children With High Functional Pervasive Developmental Disorders Family psychoeducational therapy plus TAU, Treatment as usual - Pervasive Developmental Disorder | Phase 2 / Phase 3 | Unknown | Nagoya City University | 74 | 2010-09-01 | 2011-01-19 |
| Valproate Response in Aggressive Autistic Adolescents Valproate - Autism | Phase 3 | Unknown | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 30 | 2005-06-24 |
Autism Spectrum Disorder (3) · Autistic Disorder (2) · Intellectual Disability (1) · Nervous System Diseases (1) · Parasomnias (1) · Sleep Wake Disorders (1) · Tuberous Sclerosis (1)
Mental Disorders (6) · Neurodevelopmental Disorders (6) · Autism Spectrum Disorder (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hamartoma (1) · Heredodegenerative Disorders, Nervous System (1) · Malformations of Cortical Development (1) · Malformations of Cortical Development, Group I (1) · Neoplasms (1)
Behavior Therapy (1) · Everolimus (1) · Standard of Care (1) · Therapeutics (1) · Valproic Acid (1)
All India Institute of Medical Sciences (1) · Erasmus Medical Center (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Nagoya City University (1) · Stanford University (1) · Vanda Pharmaceuticals (1)
United States (3) · Japan (1) · Netherlands (1)
Jessica A. Hellings, M.D. (1) · Masako Suzuki, MD (1) · Sheffali Gulati, MD (1)
K08MH001516 (1)